Ignite Creation Date:
2024-05-06 @ 12:33 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01609062
Status:
TERMINATED
Last Update Posted:
2016-02-01
First Post:
2012-05-24
Brief Title:
Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MPS IVA |
| Mucopolysaccharidosis IVA |
| Morquio A Syndrome |
Keywords:
| Name | View |
|---|---|
| Mucopolysaccharidosis IVA Type A | View |
| MPS IVA Type A | View |
| Mucopolysaccharidosis IVA | View |
| MPS IVA | View |
| Morquio A Syndrome | View |
| Lysosomal Storage Disorder | View |
| LSD | View |
| N-acetylgalactosamine-6-sulfatase | View |
| N-acetylgalactosamine-6-sulfate | View |
| sulfatase | View |
| galactose-6-sulfatase | View |
| GALNS | View |
| enzyme replacement therapy | View |
| ERT | View |
| MOR-008 | View |
| CPET | View |
| MST | View |
| muscle strength test | View |
| physiological effect | View |